作者
Li Fan, Omar Jabado, Nora Pencheva, Patricia Coutinho de Souza, Brandon Higgs, Angelo Harris, Patrick Franken, Anantharaman Muthuswamy, Maria Jure-Kunkel, Suzana Couto, Kate Sasser, Mark Fereshteh
发表日期
2022/6/15
研讨会论文
Cancer Research
卷号
82
期号
12
出版商
AMER ASSOC CANCER RESEARCH
简介
• Immune checkpoint inhibitor (ICI) therapy has improved outcomes in non-small cell lung cancer (NSCLC). However, the long-term benefit of ICI therapy is only observed in a subset of patients and often lacks duration.
学术搜索中的文章
L Fan, O Jabado, N Pencheva, PC de Souza, B Higgs… - Cancer Research, 2022